- Home
- TALKW vs MDCXW Comparison
TALKW vs MDCXW Comparison
Compare TALKW & MDCXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | TALKW | MDCXW |
|---|---|---|
| Founded | 2012 | N/A |
| Country | United States | Canada |
| Employees | 521 | 12 |
| Industry | Medical/Nursing Services | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | N/A | N/A |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | TALKW | MDCXW |
|---|---|---|
| Price | $0.01 | $0.92 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 64.2K | 6.0K |
| Earning Date | 02-20-2025 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $181,291,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 31.50 | N/A |
| 52 Week Low | $0.20 | $1.12 |
| 52 Week High | $0.24 | $1.34 |
Technical Indicators
Market Signals| Indicator | TALKW | MDCXW |
|---|---|---|
| Relative Strength Index (RSI) | 30.09 | 58.46 |
| Support Level | $0.02 | $0.75 |
| Resistance Level | $0.02 | $0.83 |
| Average True Range (ATR) | 0.00 | 0.05 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 9.19 | 71.82 |
Price Performance
Historical ComparisonAbout TALKW Talkspace Inc. Warrant
Talkspace Inc is a behavioral healthcare company offering access to licensed therapists, psychologists, and psychiatrists through its technology platform. It serves clients including health plans, enterprises, and individual subscribers. Therapists address various mental health conditions, while psychiatrists cater to a higher acuity demographic. Revenue stems from payor and direct-to-enterprise clients, with contracts lasting one to three years. The majority of the Company's operations and revenues are based in the United States.
About MDCXW Medicus Pharma Ltd. Warrant
Medicus Pharma Ltd is a clinical-stage holding company focused on investing in and accelerating novel life sciences and bio-technology companies through FDA-approved clinical trials. The Company focuses on meeting the unmet need to improve patient safety and efficacy.